The  ||| S:0 E:4 ||| DT
importance  ||| S:4 E:15 ||| NN
and  ||| S:15 E:19 ||| CC
features  ||| S:19 E:28 ||| NNS
of  ||| S:28 E:31 ||| IN
the  ||| S:31 E:35 ||| DT
distal  ||| S:35 E:42 ||| JJ
airways  ||| S:42 E:50 ||| NN
in  ||| S:50 E:53 ||| IN
children  ||| S:53 E:62 ||| NNS
and  ||| S:62 E:66 ||| CC
adults  ||| S:66 E:73 ||| NNS
Asthma  ||| S:73 E:80 ||| NNP
remains  ||| S:80 E:88 ||| VBZ
a  ||| S:88 E:90 ||| DT
major  ||| S:90 E:96 ||| JJ
problem  ||| S:96 E:104 ||| NN
worldwide ||| S:104 E:113 ||| NN
,  ||| S:113 E:115 ||| ,
even  ||| S:115 E:120 ||| RB
with  ||| S:120 E:125 ||| IN
new  ||| S:125 E:129 ||| JJ
categories  ||| S:129 E:140 ||| NNS
of  ||| S:140 E:143 ||| IN
medications  ||| S:143 E:155 ||| NNS
that  ||| S:155 E:160 ||| WDT
have  ||| S:160 E:165 ||| VBP
been  ||| S:165 E:170 ||| VBN
brought  ||| S:170 E:178 ||| VBN
into  ||| S:178 E:183 ||| IN
the  ||| S:183 E:187 ||| DT
therapeutic  ||| S:187 E:199 ||| JJ
armamentarium ||| S:199 E:212 ||| NN
.  ||| S:212 E:214 ||| .
One  ||| S:214 E:218 ||| CD
area  ||| S:218 E:223 ||| NN
of  ||| S:223 E:226 ||| IN
disease  ||| S:226 E:234 ||| NN
pathology  ||| S:234 E:244 ||| NNS
and  ||| S:244 E:248 ||| CC
physiology  ||| S:248 E:259 ||| NNS
that  ||| S:259 E:264 ||| WDT
is  ||| S:264 E:267 ||| VBZ
involved  ||| S:267 E:276 ||| VBN
in  ||| S:276 E:279 ||| IN
the  ||| S:279 E:283 ||| DT
pathobiology  ||| S:283 E:296 ||| NN
of  ||| S:296 E:299 ||| IN
asthma  ||| S:299 E:306 ||| NN
is  ||| S:306 E:309 ||| VBZ
the  ||| S:309 E:313 ||| DT
distal  ||| S:313 E:320 ||| NN
( ||| S:320 E:321 ||| -LRB-
small ||| S:321 E:326 ||| JJ
)  ||| S:326 E:328 ||| -RRB-
airways ||| S:328 E:335 ||| NN
.  ||| S:335 E:337 ||| .
Better  ||| S:337 E:344 ||| JJR
understanding  ||| S:344 E:358 ||| NN
of  ||| S:358 E:361 ||| IN
this  ||| S:361 E:366 ||| DT
area  ||| S:366 E:371 ||| NN
in  ||| S:371 E:374 ||| IN
both  ||| S:374 E:379 ||| PDT
the  ||| S:379 E:383 ||| DT
pediatric  ||| S:383 E:393 ||| JJ
and  ||| S:393 E:397 ||| CC
adult  ||| S:397 E:403 ||| NN
asthmatic  ||| S:403 E:413 ||| NN
populations  ||| S:413 E:425 ||| NNS
will  ||| S:425 E:430 ||| MD
lead  ||| S:430 E:435 ||| VB
to  ||| S:435 E:438 ||| TO
improved  ||| S:438 E:447 ||| JJ
targeted  ||| S:447 E:456 ||| JJ
therapy  ||| S:456 E:464 ||| NN
for  ||| S:464 E:468 ||| IN
all  ||| S:468 E:472 ||| DT
asthmatic  ||| S:472 E:482 ||| JJ
patients ||| S:482 E:490 ||| NNS
.  ||| S:490 E:492 ||| .
This  ||| S:492 E:497 ||| DT
article  ||| S:497 E:505 ||| NN
discusses  ||| S:505 E:515 ||| VBD
the  ||| S:515 E:519 ||| DT
importance  ||| S:519 E:530 ||| NN
of  ||| S:530 E:533 ||| IN
the  ||| S:533 E:537 ||| DT
distal  ||| S:537 E:544 ||| JJ
airways  ||| S:544 E:552 ||| NN
for  ||| S:552 E:556 ||| IN
both  ||| S:556 E:561 ||| DT
children  ||| S:561 E:570 ||| NNS
and  ||| S:570 E:574 ||| CC
adults  ||| S:574 E:581 ||| NNS
with  ||| S:581 E:586 ||| IN
asthma ||| S:586 E:592 ||| NN
.  ||| S:592 E:594 ||| .
